134 related articles for article (PubMed ID: 8902396)
1. Chimerism and central tolerance.
Sykes M
Curr Opin Immunol; 1996 Oct; 8(5):694-703. PubMed ID: 8902396
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
Sykes M
Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
[TBL] [Abstract][Full Text] [Related]
3. Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.
Yang YG
Springer Semin Immunopathol; 2004 Nov; 26(1-2):187-200. PubMed ID: 15378269
[TBL] [Abstract][Full Text] [Related]
4. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
[TBL] [Abstract][Full Text] [Related]
5. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
7. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.
Huang CA; Fuchimoto Y; Scheier-Dolberg R; Murphy MC; Neville DM; Sachs DH
J Clin Invest; 2000 Jan; 105(2):173-81. PubMed ID: 10642595
[TBL] [Abstract][Full Text] [Related]
8. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
9. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.
Sharabi Y; Aksentijevich I; Sundt TM; Sachs DH; Sykes M
J Exp Med; 1990 Jul; 172(1):195-202. PubMed ID: 1972728
[TBL] [Abstract][Full Text] [Related]
10. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
[TBL] [Abstract][Full Text] [Related]
11. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.
Manilay JO; Pearson DA; Sergio JJ; Swenson KG; Sykes M
Transplantation; 1998 Jul; 66(1):96-102. PubMed ID: 9679828
[TBL] [Abstract][Full Text] [Related]
12. Mixed hematopoietic chimerism and transplantation tolerance.
Nikolic B; Sykes M
Immunol Res; 1997; 16(3):217-28. PubMed ID: 9379073
[TBL] [Abstract][Full Text] [Related]
13. Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier.
Abe M; Qi J; Sykes M; Yang YG
Blood; 2002 May; 99(10):3823-9. PubMed ID: 11986242
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
[TBL] [Abstract][Full Text] [Related]
15. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning.
Sykes M; Szot GL; Swenson KA; Pearson DA
Nat Med; 1997 Jul; 3(7):783-7. PubMed ID: 9212108
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
17. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. III. Significance of hemopoietic stem cells for induction and maintenance of Mls tolerance by continuous supply of tolerance-inducing nonlymphocytes.
Hosono M; Hosokawa T; Kina T; Katsura Y
Cell Immunol; 1987 Aug; 108(1):162-74. PubMed ID: 2886228
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
[TBL] [Abstract][Full Text] [Related]
19. Induction of bilateral transplantation tolerance to cellular and perfused allografts and xenografts with donor hematopoietic cells.
Slavin S; Gurevitch O; Prighozina T
Ann N Y Acad Sci; 1998 Dec; 862():37-44. PubMed ID: 9928204
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.
Seung E; Mordes JP; Rossini AA; Greiner DL
J Clin Invest; 2003 Sep; 112(5):795-808. PubMed ID: 12952928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
